Semler Scientific, Inc. (NASDAQ:SMLR) Shares Sold by Bank of New York Mellon Corp

Bank of New York Mellon Corp reduced its stake in shares of Semler Scientific, Inc. (NASDAQ:SMLR) by 5.2% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 16,611 shares of the company’s stock after selling 907 shares during the period. Bank of New York Mellon Corp owned approximately 0.18% of Semler Scientific worth $897,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. IFP Advisors Inc acquired a new position in shares of Semler Scientific in the fourth quarter valued at about $54,000. Quest Partners LLC boosted its position in Semler Scientific by 48.0% in the third quarter. Quest Partners LLC now owns 2,520 shares of the company’s stock valued at $59,000 after buying an additional 817 shares during the last quarter. Global Retirement Partners LLC increased its holdings in Semler Scientific by 62.5% in the 4th quarter. Global Retirement Partners LLC now owns 1,300 shares of the company’s stock worth $70,000 after buying an additional 500 shares during the period. Sanctuary Advisors LLC purchased a new position in Semler Scientific during the 3rd quarter worth approximately $104,000. Finally, Verition Fund Management LLC acquired a new stake in Semler Scientific during the 3rd quarter valued at approximately $251,000. 49.37% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Separately, Lake Street Capital raised their target price on shares of Semler Scientific from $40.00 to $71.00 and gave the stock a “buy” rating in a report on Friday, January 24th.

Semler Scientific Stock Down 1.2 %

Shares of SMLR stock opened at $42.38 on Wednesday. Semler Scientific, Inc. has a 52-week low of $20.88 and a 52-week high of $81.56. The stock has a market cap of $406.72 million, a PE ratio of 8.63 and a beta of 1.33. The business has a 50-day simple moving average of $46.78 and a 200-day simple moving average of $44.62.

Semler Scientific (NASDAQ:SMLR) last announced its quarterly earnings results on Tuesday, February 18th. The company reported $3.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.20 by $3.21. Semler Scientific had a return on equity of 50.77% and a net margin of 72.65%. The company had revenue of $12.41 million during the quarter.

About Semler Scientific

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.